• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻成人软组织IV期透明细胞肉瘤的管理挑战:病例报告及文献综述

Challenges in the Management of Stage IV Clear Cell Sarcoma of Soft Tissue in Young Adults: Case Report and Review of the Literature.

作者信息

Iordache Diana, Kövendi Anita-Andrea, Fekete Zsolt, Popița Raluca, Cebotaru Iunia Patricia, Patka Annamaria, Năstase Ioana Cristina, Cebotaru Cristina Ligia

机构信息

"Iuliu Hațieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Institute of Oncology "Prof Dr. Ion Chiricuță", Cluj-Napoca, Romania.

出版信息

Case Rep Oncol. 2024 Sep 4;17(1):988-994. doi: 10.1159/000540084. eCollection 2024 Jan-Dec.

DOI:10.1159/000540084
PMID:39474564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11521404/
Abstract

INTRODUCTION

Clear cell sarcoma (CCS) of soft tissue is a rare type of soft tissue sarcoma affecting usually lower extremities in young adults. The main challenges in the management of this disease include difficulties in diagnosis, aggressiveness of the cancer with rapid progression, and inadequate treatment, especially in small centers with few cases.

CASE PRESENTATION

We present a case of a young woman diagnosed with CCS of soft tissue, stage IV. The patient benefited from a multidisciplinary approach including radiation therapy, surgery, chemotherapy, and targeted therapy with disease progression regardless of the therapeutic act. Despite all the efforts, the patient died from complications overlapping progression of the disease.

CONCLUSION

The rarity of this sarcoma limits the amount of information available on the diagnosis and treatment process. The particularity of this case is the difficulty met in maintaining the disease under control using all the resources available due to lack of compliance of the patient in carrying out amputation at diagnosis, thus modifying the entire treatment algorithm. Targeted therapy showed promising results in the literature, however in our case resulted in an unexpected, rare adverse event aggravating the patient's condition. In conclusion, patients with CCS should be referred to specialized centers for adequate multidisciplinary management and, if available, inclusion in clinical trials. New agents are needed to improve the survival of these patients.

摘要

引言

软组织透明细胞肉瘤(CCS)是一种罕见的软组织肉瘤类型,通常影响年轻成年人的下肢。该疾病管理中的主要挑战包括诊断困难、癌症侵袭性强且进展迅速以及治疗不足,尤其是在病例较少的小中心。

病例报告

我们报告一例诊断为IV期软组织CCS的年轻女性病例。患者受益于多学科方法,包括放疗、手术、化疗和靶向治疗,但无论采取何种治疗措施,疾病仍进展。尽管付出了所有努力,患者最终死于与疾病进展重叠的并发症。

结论

这种肉瘤的罕见性限制了有关诊断和治疗过程的可用信息量。该病例的特殊性在于,由于患者在诊断时不配合截肢,导致难以利用所有可用资源控制疾病,从而改变了整个治疗方案。靶向治疗在文献中显示出有前景的结果,但在我们的病例中却导致了意想不到的罕见不良事件,加重了患者的病情。总之,CCS患者应转诊至专业中心进行充分的多学科管理,如有可能,应纳入临床试验。需要新的药物来提高这些患者的生存率。

相似文献

1
Challenges in the Management of Stage IV Clear Cell Sarcoma of Soft Tissue in Young Adults: Case Report and Review of the Literature.年轻成人软组织IV期透明细胞肉瘤的管理挑战:病例报告及文献综述
Case Rep Oncol. 2024 Sep 4;17(1):988-994. doi: 10.1159/000540084. eCollection 2024 Jan-Dec.
2
Clear cell sarcoma of soft tissue: a retrospective review and analysis of 31 cases treated at Istituto Ortopedico Rizzoli.软组织透明细胞肉瘤:Istituto Ortopedico Rizzoli 治疗的 31 例回顾性分析。
Eur J Surg Oncol. 2014 May;40(5):505-510. doi: 10.1016/j.ejso.2014.01.016. Epub 2014 Feb 2.
3
Intestinal Clear Cell Sarcoma-A Case Presentation of an Extremely Rare Tumor and Literature Review.肠透明细胞肉瘤——一种极其罕见肿瘤的病例报告及文献复习。
Medicina (Kaunas). 2024 May 22;60(6):847. doi: 10.3390/medicina60060847.
4
Navigating diagnostic challenges-distinguishing malignant melanoma and clear cell sarcoma of soft tissues: a case report and review of the literature.诊断挑战:恶性黑色素瘤与软组织透明细胞肉瘤的鉴别——病例报告及文献复习
J Med Case Rep. 2024 May 17;18(1):249. doi: 10.1186/s13256-024-04542-y.
5
Superficial Clear Cell Sarcoma (Melanoma of Soft Parts) of the Large toe in an 80-Year-Old Female With a Rare Cytogenetic Translocation.一名80岁女性大脚趾的浅表性透明细胞肉瘤(软组织黑色素瘤)伴罕见细胞遗传学易位
Cureus. 2020 Nov 26;12(11):e11719. doi: 10.7759/cureus.11719.
6
Is High-dose Radiation Therapy Associated With Early Revision Due to Aseptic Loosening in Patients With a Sarcoma of the Lower Extremities Reconstructed With a Cemented Endoprosthesis?高剂量放疗是否会增加下肢肉瘤行骨水泥型假体重建术后因无菌性松动导致早期翻修的风险?
Clin Orthop Relat Res. 2023 Mar 1;481(3):475-487. doi: 10.1097/CORR.0000000000002360. Epub 2022 Aug 17.
7
Clear cell sarcoma of soft tissue in pleural cavity: A case report.胸腔软组织透明细胞肉瘤:一例报告
World J Clin Cases. 2019 Oct 6;7(19):3126-3131. doi: 10.12998/wjcc.v7.i19.3126.
8
A case of clear cell sarcoma-A rare malignancy.一例透明细胞肉瘤——一种罕见的恶性肿瘤。
Int J Surg Case Rep. 2017;36:151-154. doi: 10.1016/j.ijscr.2017.05.034. Epub 2017 Jun 1.
9
Unusual Clinical Presentation of Clear Cell Sarcoma in a Young Woman.年轻女性中透明细胞肉瘤的不典型临床表现。
Oncology (Williston Park). 2023 Oct 10;37(10):412-416. doi: 10.46883/2023.25921005.
10
Esophageal extraskeletal neoplasm Ewing's sarcoma: Case report.食管骨外肿瘤尤因肉瘤:病例报告
Int J Surg Case Rep. 2022 Aug;97:107399. doi: 10.1016/j.ijscr.2022.107399. Epub 2022 Jul 9.

本文引用的文献

1
Targeting the Clear Cell Sarcoma Oncogenic Driver Fusion Gene by HDAC Inhibition.靶向透明细胞肉瘤致癌驱动融合基因的组蛋白去乙酰化酶抑制。
Cancer Res Commun. 2023 Jul 3;3(7):1152-1165. doi: 10.1158/2767-9764.CRC-22-0518. eCollection 2023 Jul.
2
Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma Network.晚期透明细胞肉瘤的系统性治疗:来自世界肉瘤网络的回顾性国际系列研究结果。
ESMO Open. 2022 Jun;7(3):100522. doi: 10.1016/j.esmoop.2022.100522. Epub 2022 Jun 17.
3
Posterior reversible encephalopathy syndrome (PRES): diagnosis and management.
后部可逆性脑病综合征(PRES):诊断与治疗。
Pract Neurol. 2022 Jun;22(3):183-189. doi: 10.1136/practneurol-2021-003194. Epub 2022 Jan 19.
4
New TNM classification (AJCC eighth edition) of bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group.骨与软组织肉瘤的新TNM分类(美国癌症联合委员会第八版):日本临床肿瘤学会骨与软组织肿瘤研究组
Jpn J Clin Oncol. 2019 Feb 1;49(2):103-107. doi: 10.1093/jjco/hyy157.
5
Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature.帕唑帕尼(一种多靶点酪氨酸激酶抑制剂)引起的软组织肉瘤患者的后部可逆性脑病综合征(PRES):病例报告及文献复习。
Invest New Drugs. 2018 Apr;36(2):346-349. doi: 10.1007/s10637-017-0521-5. Epub 2017 Oct 25.
6
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.MET 改变的晚期透明细胞肉瘤患者中克唑替尼的活性和安全性:欧洲癌症研究与治疗组织 90101“CREATE”期 2 试验。
Ann Oncol. 2017 Dec 1;28(12):3000-3008. doi: 10.1093/annonc/mdx527.
7
Biology and management of clear cell sarcoma: state of the art and future perspectives.透明细胞肉瘤的生物学特性与管理:现状与未来展望
Expert Rev Anticancer Ther. 2016 Aug;16(8):839-45. doi: 10.1080/14737140.2016.1197122. Epub 2016 Jun 20.
8
Objective response to sorafenib in advanced clear-cell sarcoma.索拉非尼对晚期透明细胞肉瘤的客观反应。
Ann Oncol. 2012 Mar;23(3):807-809. doi: 10.1093/annonc/mds005. Epub 2012 Jan 24.
9
Tumor response to sunitinib malate observed in clear-cell sarcoma.在透明细胞肉瘤中观察到的肿瘤对苹果酸舒尼替尼的反应。
Ann Oncol. 2010 May;21(5):1130-1. doi: 10.1093/annonc/mdp611. Epub 2010 Jan 21.
10
Reversible posterior leucoencephalopathy syndrome associated with anticancer drugs.与抗癌药物相关的可逆性后部白质脑病综合征。
Intern Med J. 2009 Dec;39(12):826-34. doi: 10.1111/j.1445-5994.2008.01829.x. Epub 2008 Nov 3.